Agios Pharmaceuticals | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 3.32B 2.71B 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Arrowhead Research USD 52.59M 132.85M 2024-12
Astellas Pharma JPY 1.49T 36.03B 2024-12
AstraZeneca USD 40.87B 66M 2024-12
Bayer EUR 32.04B 1.49B 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Daiichi Sankyo JPY 1.62T 1.57B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Exelixis USD 2.24B 31.22M 2025-01
Gilead Sciences USD 19.33B 856M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
Incyte USD 3.45B 276.41M 2024-12
Ionis Pharmaceuticals USD 588.35M 74.12M 2024-12
Merck USD 46.31B 1.81B 2024-12
Moderna USD 10.9B 1.03B 2024-12
Novartis USD 44.05B 605M 2024-12
Novartis USD 44.05B 729M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Agios Pharmaceuticals Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.